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Objectives: The goal of this study was to evaluate the early results of fenestrated endovascular aortic repair (f-EVAR) using custom-made stent graft (CMSG) or physician-modified stent graft (PMSG) to revascularize the visceral artery for the patients with abdominal aortic aneurysm (AAA) or dissection involving visceral artery.
Methods: We evaluated the early results of fenestrated endovascular aortic repair (f-EVAR) using custom-made stent graft (CMSG) or physician-modified stent graft (PMSG) to revascularize the visceral artery for the patients with AAA or dissection involving visceral artery.
Results: The median patient age was 67 years (range, 49-75 years), and seven of the nine patients (77.78%) were men. One CMSG and eight PMSGs were deployed. Indications were AAA with short infrarenal proximal landing zone (n ¼ 8) and chronic dissection involving visceral arteries (n ¼ 1). Twenty-two visceral arteries were revascularized (15 renal arteries, 6 superior mesenteric arteries, 1 celiac artery). Median duration for stent graft modifications was 55 minutes (range, 30-75 minutes) . PMSGs with 1 fenestration were deployed for 2 patients, 1 fenestration combined with 1 scallop for 1 case, 2 fenestrations for 1 case, 2 fenestrations combined with 1 scallop for 4 cases, and 4 fenestrations for 1 case. Primary technical success rate was 88.89% (8 of 9). One type III endoleak occurred. Mean operative time was 181 6 45 minutes, and fluoroscopy time was 45 6 28 minutes. There were no in-hospital deaths and no perioperative mesenteric ischemia complications. Median length of postoperative stay was 10 6 6 days (range, 7-28 days). Renal dysfunction occurred in three cases during 7 postoperative days and improved with medical treatment. Mean follow-up period was 8.6 months (range, 1-24 months). The Doppler follow-up for two cases with renal dysfunction at 3 months showed no endoleak and patency of PMSG and branch stent graft. Computed tomography angiography was performed for other seven cases postoperatively. One branch stent graft was found occluded at 6 months. Patency and no endoleak of fenestrated stent graft and branch stent grafts were found from the images of another six cases.
Conclusions: F-EVAR with PMSG may be a viable alternative for patients with AAA or dissection involving visceral artery and unable to wait for CMSG.
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Long Objectives: Endovascular aneurysm repair has been shown to reduce mortality in the emergent repair of ruptured abdominal aortic aneurysms (AAA). However, long-term survival data for this group of patients are lacking with contemporary endovascular endografts. The purpose of this study was to evaluate 30-day mortality rates and 1-year survival in patients undergoing emergent EVAR in a 43-facility hospital system with a quaternary referral center with an established ruptured aneurysm protocol.
Methods: This was a retrospective analysis of patients captured prospectively in an Institutional Review Board-approved registry for patients treated emergently for AAA 2012 and 2017. Primary outcome measures were 30-day mortality and 1-year survival for the entire group, as well as for symptomatic and ruptured aneurysms. Data were analyzed using logistic regression survival curves, and a log-rank test was performed to compare survival between open and endovascular repair. Patients were evaluated on an intent-to-treat basis and outcomes evaluated in a multivariate model.
Results: A total of 249 patients were referred as part of the protocol. Of these, 102 (41%) were treated emergently. The 30-day and 1-year survival was 63% and 42% for all patients, 58% and 37% for ruptured patients, and 85% and 62% for symptomatic patients (Fig) . EVAR resulted in improved 30-day (64% vs 31%; odds ratio, 4.0; P ¼ .03) and 1-year survival (40% vs 23%; odds ratio, 2.3; P ¼ .35) over open repair. Significant predictors for 30-day mortality included hypotension (P ¼ .0003), blood transfusion (P < .0001), length of stay (P ¼ .0005), extravasation (P ¼ .01), preoperative cardiopulmonary resuscitation (P ¼ .04), open repair (P ¼ .0068), aortouniiliac reconstruction (P ¼ .0079), and abdominal compartment syndrome (P ¼ .0067). Significant predictors for 1-year mortality included advanced age (P ¼ .04), hypotension (P ¼ .01), blood transfusion (P ¼ .006), extravasation (P ¼ .03), reintubation (P ¼ .03), and abdominal compartment syndrome (P ¼ .03). There were no differences in outcomes based on race, gender, or outside transfer. Peripheral arterial disease (P ¼ .04), hypertension (P ¼ .04), coronary artery disease (P ¼ .03), and familial history (P ¼ .05) of aneurysms was related to increased 30-day mortality. Peripheral arterial disease (P ¼ .059) and coronary artery disease (P ¼ .067) were nearly significant, with increased 1-year mortality.
Conclusions: EVAR is associated with improved survival compared to open repair in patients requiring emergent AAA repair. However, 
